We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Automated Workflow Offers PCR-Based Molecular Diagnostic Assay Menu

By LabMedica International staff writers
Posted on 01 Sep 2010
A novel, integrated system sets new standards for molecular testing and incorporates all workflow steps from sample to detection.

The system offers features that create flexibility, such as continuous loading, random access, open channels for user-developed tests, and a very broad menu of commercial assays. More...
It has the ability to process an almost unlimited range of sample types and it should transform the laboratory's work in the emerging field of molecular diagnostic

This new and complete workflow solution is comprised of modules that can be used as standalone systems or combined into a fully integrated system. Called QIAsymphony RGQ, and introduced by Qiagen (Frankfurt, Germany), the system comprises the physical and data integration of the modules QIAsymphony SP for sample preparation, QIAsymphony AS for assay setup, and the Rotor-Gene Q real time polymerase chain reaction (PCR) thermocycler.

QIAsymphony provides the broadest available PCR-based assay menu, including the Artus real time PCR kits for the detection of human immunosuppression virus (HIV), Human hepatitis C and B viruses (HCV, HBV), and a transplantation panel with Cytomegalovirus (CMV), Epstein Bar virus (EBV), Herpes simplex virus (HSV), Varicella-Zoster (VZV) and BK virus (BKV1). (BK was the initials of the patient from whom the virus was first isolated).

A large pipeline of more tests will be launched in the coming months, including TheraScreen, epidermal growth factor receptor (EGFR), KRAS, as well as Artus Influenza, Computed tomography (CT), CT Neisseria gonorrhoeae (CT/Ng) and an extended transplantation panel. Many more tests are in development including integration of detection options such as pyrosequencing and multiplexing solutions.

Qiagen N.V., a Netherlands holding company, is a global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA, and proteins from biological samples such as blood or tissue. Assay technologies are used to make such isolated bio-molecules visible.

Related Links:
Qiagen



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.